Evidence that fold-change, and not absolute level, of β-catenin dictates Wnt signaling by Goentoro, Lea & Kirschner, Marc W.
Evidence that fold-change, and not absolute level, of β-catenin
dictates Wnt signaling
Lea Goentoro and Marc W. Kirschner
Department of Systems Biology, Harvard Medical School, Boston, MA 02115
SUMMARY
In the canonical Wnt pathway, binding of the Wnt ligand to its transmembrane receptors leads to
an inhibition of the degradation of β-catenin; as a result, β-catenin accumulates to a point where it
activates target genes. Using mathematical modeling and experiments in mammalian cells, we
examined the robustness of the β-catenin response to Wnt stimulation. We found that the final
(post-Wnt) level of β-catenin is very sensitive to all perturbations in the Wnt signaling pathway,
such that mild genetic or environmental variation would be expected to change the final level of β-
catenin, and alter the output of the pathway. By contrast, one unusual parameter was robust: the
fold-change in β-catenin (post- Wnt level / pre-Wnt level). Furthermore, in Xenopus embryos,
dorsal-anterior development and the corresponding target gene expression are robust to the same
perturbations that alter the final level but leave the fold-change intact. These results suggest: First,
despite noise and variation, within a range the cell maintains a constant fold-change in β-catenin
for a given Wnt stimulation. Second, the transcriptional machinery downstream of the Wnt
pathway is constructed to read the robust fold-change and not simply the final level of β-catenin.
In analogy to Weber’s law in sensory physiology, some gene transcription networks may be tuned
to respond to fold-changes, rather than absolute levels of signals, as a way to reduce the
consequences of stochastic, genetic and environmental variation.
INTRODUCTION
The canonical Wnt signaling pathway is highly conserved and broadly employed in
multicellular animals (for example, in patterning embryonic body plans (Riggleman et al.,
1990) and maintaining stem cell homeostasis (Korinek et al., 1998)). Mutations in the Wnt
pathway are implicated in disease, notably colorectal cancer (Rubinfeld et al., 1993; Su et
al., 1993) and hepatocellular carcinoma (Satoh et al., 2000). The intermediary signal in the
Wnt pathway is a protein called β-catenin. In the absence of a Wnt signal, β-catenin is
maintained at low levels by rapid degradation (van Leeuwen et al., 1994) (Figure 1A).
Degradation is mediated by a protein complex, whose components include multiple kinases
(GSK3βand CKIα) and scaffolds (APC and Axin1) (Hart et al., 1998; Ikeda et al., 1998; Itoh
et al., 1998; Liu et al., 2002; Peifer et al., 1994b; Rubinfeld et al., 1993; Salic et al., 2000; Su
et al., 1993; Zeng et al., 1997). The destruction complex phosphorylates β-catenin and
targets it to a ubiquitin ligase and ultimately to the proteosome (Aberle et al., 1997; Liu et
al., 2002; Orford et al., 1997; Peifer et al., 1994a; van Noort et al., 2002; Yost et al., 1996).
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Binding of the Wnt ligand to the extracellular domains of two transmembrane receptors
leads to the inhibition of the activity of the destruction complex in the cytosol (Bhanot et al.,
1996; Pinson et al., 2000; Tamai et al., 2000; Wehrli et al., 2000). As a result, β-catenin
accumulates to a high level (Figure 1A).
The increased amount of β-catenin, in conjunction with Tcf/Lef transcription factors,
activates transcription of specific target genes (Figure 1B) (Behrens et al., 1996; Molenaar et
al., 1996; Peifer et al., 1994b; van Leeuwen et al., 1994). In this way it is thought that
phenotypic responses to β-catenin, whether normal or pathological, are consequences of the
elevated level of the protein. While it was observed that a high level of β-catenin in cancer
cells correlates with hyper-active Wnt responses (Klaus and Birchmeier, 2008), the
quantitative features of this correlation have not been fully explored. What is not known, for
instance, is how precisely the cell controls the level of β-catenin in the absence of the Wnt
ligand, and how precisely it controls the level of β-catenin in response to the Wnt ligand,
and if these levels are robustly maintained, and by what means they are controlled.
Given the importance of Wnt signaling, we were somewhat surprised to find, first through
theory and then through experiments, that response of this pathway, the level of β-catenin,
was very sensitive to relatively small perturbations in Wnt pathway parameters (Figure 1C).
Parameters in the Wnt pathway include levels of scaffolds, kinases, kinetic rate constants,
binding equilibrium and so on. This result holds for the level of β-catenin either before or,
more significantly, after Wnt stimulation. This means that natural variation, either genetic,
environmental or stochastic, could significantly change the output of Wnt signaling. This is
a real concern as there is increasing evidence that the level of a protein, for example, might
vary by 4-fold across a population of cells due to stochasticity alone (Alon, 2007; Bar-Even
et al., 2006; Blake et al., 2006; Blake et al., 2003; Elowitz et al., 2002; Ozbudak et al., 2002;
Paulsson, 2004; Raser and O’Shea, 2004). The concern is that the level of β-catenin would
vary from cell to cell, as a result of the stochastic variation of the numerous other proteins in
the pathway.
While the level of β-catenin was shown to be fine-tuned, our analysis revealed that another
measure of the response of the pathway is robust to most perturbations in the Wnt pathway:
the fold-change in β-catenin, defined as the ratio of the β-catenin level after Wnt stimulation
to the level of β-catenin before Wnt stimulation (Figure 1A, D). We confirmed this
prediction experimentally where we perturbed components of the pathway in mammalian
cells, by overexpression and pharmacological inhibitors. In this system we could measure
accurately the pre-Wnt level, the post-Wnt level, and the fold-change in β-catenin in
response to Wnt. To probe further the biological relevance of this behaviour, we turned to a
quantitative study of Wnt signaling in Xenopus embryos. The anatomical phenotype in the
early embryo correlated with the Wnt-induced fold-change in β-catenin, and not with the
absolute levels of β-catenin. Perturbations that affected the final level of β-catenin and the
fold-change altered the phenotype; perturbations that similarly affected the final level but
not the fold-change did not alter the normal phenotype. Therefore, fold-change in the level
of β-catenin induced by Wnt, and not the final level itself, should potentially be a precise
reporter of Wnt signal that is read by the downstream transcriptional system (Figure 1E).
The robustness of the fold-change response holds over a limited range (approximately a
fourfold range) of perturbation of the internal components of the pathway; this would be
expected to cover the range of naturally occurring noise in protein levels found in many
systems (Alon, 2007 and the references therein). Extreme perturbations such as knockdowns
and knockouts should overwhelm this buffering, as they do. For this reason it would
probably difficult to detect this property previously, unless one were expecting it and testing
for it. For example, we show that Wnt stimulation gives a constant fold-change response to
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the commonly used GSK-3 inhibitors (lithium chloride and BIO), but this was only revealed
when we examined concentrations of inhibitors lower than usually used. Experiments in
Xenopus embryos commonly use concentrations as high as 0.3M LiCl, which exceeds the
buffered range, whereas at lower concentrations, LiCl significantly perturbs the level of β-
catenin without affecting the fold-change or the embryonic morphology.
Having the output of the Wnt signaling circuit in the form of fold-change may explain its
robustness. Nevertheless, it raises questions about how the transcriptional circuits
downstream could respond to fold-changes (Figure 1E). The downstream transcriptional
response system must first remember the level of β-catenin before the Wnt signal, and then
compare it to the level of β-catenin after the Wnt signal. In other words, responding to fold-
changes requires that the transcriptional machinery measure a temporal ratio of the basal
state to the stimulated state. We show that in Xenopus embryos the natural target gene
circuits are constructed to respond to fold-changes in β-catenin, and not the absolute levels,
while artificial promoters comprising only Tcf-Lef/β-catenin binding sites do not show this
property. In the following paper, in collaboration with Uri Alon and Oren Shoval, we show
how a common transcriptional motif, the incoherent feed forward loop has a remarkable
ability to be a fold-change detector.
Modeling analysis predicts that the Wnt induced fold-change in β-catenin is insensitive to
variation in most pathway parameters
To study the robustness of the Wnt pathway to variation in its internal parameters, we
started with a published mathematical model (Figure 2A) (Lee et al., 2003), describing
detailed kinetics of the cytosolic interactions in the Wnt pathway. The model was shown to
capture well the effects of various perturbations in Xenopus extracts (e.g., immunodepletion,
overexpression, and drug addition, on the flux of β-catenin degradation). Detailed
measurements of the rate constants, equilibrium constants, concentrations, and fluxes in the
Xenopus extracts permitted evaluation of all parameters within the model.
When we set up the model and perturbed the Xenopus parameters one at a time, mimicking
natural variation in biochemical parameters, we found that the basal level of β-catenin, the
β-catenin level after Wnt stimulation, the difference between the basal and final level, the
response time, the integrated level, the integrated difference and the integrated fold-change
varied extensively with parameters (Figures 2B and S1). By contrast, the Wnt-induced fold-
change in β-catenin was insensitive to perturbation in most parameters (Figure 2C). Note
that the free, non-GSK3-phosphorylated pool is plotted here, but the results hold when total
pool of β-catenin (the measurable quantity) is plotted instead (Figure S2).
As an example of the effects of perturbation in the model, when we moderately overexpress
Axin1 (v14) in the model, the basal level of β-catenin decreases (Figure 2D). The
unperturbed and the Axin1-overexpressing system with a lower level of β-catenin respond
equally to Wnt stimulation: they give the same fold-change in β-catenin. On the other hand,
overexpressing β-catenin (v12) in the model also increases the basal level of β-catenin
(Figure 2E). However, now cells with a higher level of β-catenin respond excessively to Wnt
stimulation: they give a higher fold-change in β-catenin. This numerical sensitivity analysis
serves as an illustration; the thorough multi-parameter sensitivity will be addressed by the
analytical solution presented next.
To understand how the Wnt-induced fold-change in β-catenin, and not the absolute levels of
β-catenin, can buffer variation in parameters, we analyzed the model further. As illustrated
by the colour shadings in Figure 2, the parameters group in a meaningful way. For example,
the fold-change in β-catenin is sensitive to most parameters, all of which characterize the
large degradation machinery (grey-shaded in Figures 2A and C). We can derive this
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grouping formally using dimensional analysis. This is an analytical tool where each variable
is scaled, such that the normalized, dimensionless variable averages around 1. As this
technique is widely used in physics and engineering, and involves relatively straightforward
albeit tedious algebra, we present the detailed derivation in the supplement. Note that this
analysis involves no further assumptions or simplification of the model; the full model is
simply rearranged into its most concise form.
Performing the scaling procedure, the numerous parameters in the steady-state model
automatically group into 3 terms: α, δ, and γ (Figure 2A). The majority of the parameters
fall into the α group, which includes the 12 parameters describing the degradation
machinery. The δ group characterizes the strength of ligand stimulation. And the small γ
group contains the synthesis rate of β-catenin and the weak binding between β-catenin and
APC (Lee et al., 2003; Rubinfeld et al., 1995). Effectively, the parameter grouping suggests
that there are 3 independent ways (“effective rates”) to increase the steady-state β-catenin
level: by increasing synthesis, inhibiting degradation, and ligand stimulation. Despite the
many independent biochemical parameters, there are only 3 independent ways to perturb β-
catenin level. Many parameters cluster and affect the system in the same way. Notably, APC
was recently shown to have a dual role in Wnt signaling (Takacs et al., 2008). Adding this
extra interaction in the model simply leads to extra parameters in α, and no changes in the
subsequent analysis (eqns. 31-32 in the supplement).
One advantage of understanding the 3 grouping of the parameters is: with a 3-dimensional
plot, we can visualize the entire behaviour of the Wnt pathway, for all possible values of
parameters. Analytically solving the model, we find that the level of β-catenin after Wnt
stimulation is always sensitive to parameters (Figure 3A). The detailed analytical solution is
presented in the supplement. As shown in Figure 3A, the level of β-catenin varies
continuously with the parameters in the large degradation machinery (α and the parameters
in the group γ.
Next we solve for the fold-change in β-catenin induced by Wnt stimulation. As shown in
Figure 3B, there is a parameter region where the fold-change in β-catenin withstands
variation in parameters (the flat region). As long as the cells operate in this parameter
region, varying most parameters, such as inhibiting GSK3β or overexpressing Axin1, will
not affect the way cells respond to Wnt stimulation (i.e., fold-change in β-catenin stays
constant)—even though the absolute levels of β-catenin itself has varied (Figure 3C). We
also analyzed the effects of the parameters in δ; as expected, the higher the Wnt
concentration, the higher the fold-change in β-catenin (Figure S3).
In the simplest model of synthesis and degradation, with ligand affecting the rate of
degradation, the Wnt-induced fold-change would stay constant despite variation in synthesis
or degradation parameters. In fact, the numerous and nonlinear interactions in the Wnt
pathway effectively behave in this simple manner within the flat region in Figure 3B. The
exit from this flat region represents a departure from a simple synthesis/degradation balance.
It is not that many interactions drop out, but many interactions are wired to make possible
the simple behaviour.
Moreover, it is not trivial to be in the parameter region where the simple behaviour is
realized. It requires maintaining a very active destruction complex (a rapid cycle of binding,
phosphorylation, and dissociation). This insight was obtained by applying a separation of
time scale, presented in the supplement. A very potent destruction complex is indeed a
hallmark of the Wnt pathway. As shown next, it appears that the simple behaviour is not
fully realized in cells.
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The Wnt-induced fold-change in β-catenin is insensitive to variation in the degradation
machinery
Do cells operate in the parameter region where the Wnt-induced fold-change in β-catenin is
insensitive to variation in many parameters? As the first evidence, we note that the
parameters measured in the Xenopus system place the Wnt pathway in the region where the
fold-change in β-catenin is insensitive to the degradation parameters (Figure 3B). This is a
nontrivial coincidence, as the model was constructed without any assumptions that it should
exhibit such a region, and the parameters were measured independently. Curiously, the
Xenopus parameters lie close to the peak region, such that the fold-change in β-catenin is
relatively sensitive to β-catenin synthesis rate (plotted later). To verify these theoretical
predictions, we perturbed these parameters and several others experimentally in mammalian
cells. The RKO colorectal cell line was chosen because it is an established model for Wnt
signaling and its analysis is simplified by the lack of cadherin-bound pool of β-catenin
(Figure 4A) (Breen et al., 1993; Giannini et al., 2000). Note again, that the term fold-change
always refers to the change in the level of β-catenin induced by Wnt, and not by any other
means.
The Wnt-induced fold-change in β-catenin is insensitive to perturbations in
the degradation process in RKO cells—If cells operate within the insensitive region,
then the Wnt-induced fold-change in β-catenin should be unaffected by moderate
perturbations in the degradation machinery (green arrow, Figure 4B). We enhanced
degradation by Axin1 overexpression, a scaffold in the destruction complex. Moderate
Axin1 overexpression decreased the basal β-catenin level by half (0.49±0.06, Figure 4D).
Remarkably, upon Wnt stimulation, both control and Axin-overexpressing cells gave nearly
the same fold-change in β-catenin (0.92±0.07, Figure 4D).
A similar precision in responding to Wnt stimulation was observed when the degradation
rate was decreased (Figures 4E-F). We inhibited GSK3β, a key kinase in the destruction
complex, using lithium and BIO (Klein and Melton, 1996; Meijer et al., 2003). The basal
and Wnt-induced level of β-catenin increased in a dose-dependent manner to lithium
treatment (Figure S5, Figure 4F). Instead of being saturated, cells with three times the basal
level of β-catenin responded to Wnt stimulation just like the control cells. The fold-change
in β-catenin (post-Wnt level / pre-Wnt level) was preserved within 20% (Figure 4F). At
higher doses of inhibitor (>40mM), the Wnt-induced fold-change eventually decreased (cells
responded less and less to Wnt stimulation). Similarly, the Wnt-induced fold-change in β-
catenin was initially unaffected by another GSK3β inhibitor, BIO (Figure S6).
The Wnt-induced fold-change in β-catenin is sensitive to perturbations in
synthesis rate in RKO cells—The model predicts both a flat region and an adjacent
peak. Though Wnt-induced fold-change in β-catenin in RKO cells is robust to perturbations
in the degradation machinery (Figure 3C), the model predicts a peak region, where Wnt
stimulation can give rise to a higher fold-change in β-catenin. It also predicts that we should
be able bring the cells to this hyper-responsive region by overexpressing β-catenin (red
arrow, Figure 4B). Cells overexpressing β-catenin (by 2.8±0.3 times, Figure 4G) are more
responsive to Wnt stimulation (Figure 4G). That is, cells overexpressing β-catenin gave a
higher fold-change in β-catenin compared to the control cells (by 1.8±0.4, Figure 4G). Thus
in the peak region, constancy of fold-change was broken.
The model explains that the weak binding between APC and β-catenin (K17~1000 nM) is
responsible for this hyper-responsiveness. Overexpressing of β-catenin (increasing γ, red
arrow in Figure 4B) can bring the system into a parameter region where this binding now
becomes strong enough to act as a positive feedback: β-catenin sequesters APC, synergizing
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with Wnt in inhibiting the destruction complex. Note that inhibiting the destruction complex
(decreasing α; green arrow in Figure 4B) also increases the level of β-catenin, but the
positive feedback is never sufficiently realized if we take this route (the surface simply
slopes down). Of course, it all depends on where we start. The model suggests that how we
increase β-catenin matters because the effect of an interaction depends on a nonlinear
combination of parameters, manifested in a non-monotonic surface manifold (Figure 4B).
In the hyper-responsive peak region, cells gave a higher fold-change in β-catenin compared
to control cells. The model predicts that from this setpoint, the fold-change in β-catenin
should now be more sensitive to perturbation in the degradation machinery (orange arrow in
Figure 4B). It is not that cells are saturated more quickly, because they actually respond
more to Wnt stimulation than the control cells (Figure 4G). When lithium treatment was
repeated on cells overexpressing β-catenin, the Wnt-induced fold-change in β-catenin
decreased more precipitously (Figure 4H). Please also see Figure S7, where the two
treatments (lithium treatment and β-catenin overexpression) were performed side-by-side.
In summary, we can observe directly how the fold-change in β-catenin withstands
perturbations in the degradation machinery, and how it fails to buffer specific perturbations.
That this was predicted by the model suggests that no new molecular mechanisms need to be
invoked. The Wnt pathway, as modelled in the present study, can already explain the
observed behaviour.
The data suggest that an insensitive region (Figure 3C) predicted by the model indeed exists,
and that RKO cells operate within this region. Independent measurements of the model
parameters performed in Lee et al., 2003 suggest that the Xenopus system also operates
within the insensitive region. These argue for the biological relevance of this region, where
the Wnt-induced fold-change in β-catenin buffers perturbations. Moreover, we can alter the
behaviour of the Wnt pathway in the specific ways predicted by the model. The data suggest
that the fold-change in β-catenin is a more precise reporter of Wnt stimulation than the
absolute level of β-catenin because it can be insensitive to most parameters that naturally
vary from cell to cell.
Phenotypic outcomes of Wnt signaling in embryonic development are robust to variation
in the degradation machinery
The relative importance of fold-changes versus absolute levels of β-catenin can be addressed
in a complex embryonic system. In Xenopus, the canonical Wnt signaling regulates the
formation of dorsal-anterior structures. Ectopic Wnt or β-catenin expression causes
duplication of dorsoanterior structures (i.e., twin-headed tadpoles) (Funayama et al., 1995;
McMahon and Moon, 1989), while blocking Wnt or β-catenin expression eliminates
dorsoanterior structures (Heasman et al., 1994; Tao et al., 2005). Globally blocking
degradation of β-catenin leads to a global increase of β-catenin (Schneider et al., 1996) and
enlarged dorsoanterior structures.
From the Xenopus setpoint, the model predicts that the Wnt-induced fold-change in β-
catenin should be relatively insensitive to variations in the large degradation machinery, and
sensitive changes in β-catenin expression (Figure 5A, please see also Figure S8 for more
details). If fold-change in β-catenin, rather than absolute level of β-catenin, dictates the
phenotypic outcome of Wnt signaling, then embryonic development should be relatively
insensitive to degradation parameters, and sensitive to β-catenin overexpression.
To test this experimentally, various perturbations were made by protein expression or
addition of inhibitors (Figure 5B). Specifically, RNA was injected at the 4-cell stage in each
blastomere; lithium exposure was at 48-cell stage. The cadherin-free pool of β-catenin was
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quantified just before gastrulation, when embryonic induction occurs; transcription
measurements were made at gastrulation; final ascertainment of morphology was performed
at day 4 when the dorsal-ventral differences are easiest to score (see also Figures S9-10). To
facilitate scoring the morphology, we used the dorsal-anterior index, which goes from 1 to
10 (DAI, Figure 5A) (Kao and Elinson, 1988). DAI 1 is the totally ventralized morphology,
observed when Wnt signaling is completely blocked (Heasman et al., 1994; Tao et al.,
2005). DAI 10 is the totally dorsalized morphology, observed when Wnt signaling is
strongly activated everywhere (Kao and Elinson, 1988). DAI 5 is the wild-type morphology.
The embryonic phenotype is robust to perturbations in the degradation machinery
To inhibit degradation of β-catenin, we overexpressed GSK3β binding protein (GBP) or
treated the embryos with lithium (inhibitor of GSK3β (Klein and Melton, 1996; Yost et al.,
1998). Inhibiting GSK3β with lithium raised the overall level of cadherin-free β-catenin in a
dose-dependent manner (Figure 5C). However, despite a 2-fold increase in the level of β-
catenin in the embryo, the embryos maintained the wild-type morphology (Figure 5C).
Eventually, at a higher dose of inhibitor (300mM), ≥40% of the embryos showed
dorsalization (Figure 5C), in agreement with published studies. The phenotypic buffering at
≤200 mM lithium is highly reproducible (Figure S11).
The embryos also remained wild type when the degradation rate was decreased by GBP
overexpression or when the degradation rate was increased by Axin1 overexpression (Figure
5D). To facilitate comparison across independent experiments, we plotted the median DAI
versus the measured β-catenin level (Figure 5D). Again, the overall cadherin-free β-catenin
level in the embryo varied with RNA dose in a dose-dependent manner. Despite a 2-fold
increase (due to GBP injection) or a 2-fold decrease (due to Axin1 injection) in the level of
β-catenin, the embryos remained wild type (Figure 5D). Higher doses of GBP or Axin1 RNA
eventually led to dorsoanterior defects, as expected from published studies (Kao and
Elinson, 1988; Kofron et al., 2001; Yost et al., 1998). As shown later in Figure 6, the “extra”
β-catenin is transcriptionally active; hence the observed phenotypic buffering is not simply
due to regulation of nuclear entry.
The embryonic phenotype is sensitive to perturbations in the β-catenin synthesis rate
In contrast to the insensitivity to perturbations of degradation, the dorsoanterior phenotype
was sensitive to β-catenin overexpression. At the equivalent overall levels of β-catenin,
increasing of synthesis had a measurable effect, whereas decreasing degradation did not.
Upon injection of β-catenin RNA, dorsalized embryos readily appear in the population
(Figures 5E-F). In response to lithium or GBP injection, β-catenin level increased by ≤2-fold
and the embryos stayed wild type. In response to β-catenin injection, β-catenin level
increased by ≤2-fold and the embryos were dorsalized.
The lack of buffering to β-catenin overexpression is highly reproducible, though the exact
morphologies show a range (Figure 5E shows the results of 4 independent 125 pg injection).
Please see Table S1 for more repeats and negative controls. Quantitation of β-catenin protein
at different stages does not alter the conclusion (Figure S12). Injection performed earlier (at
early 2-cell) led to the same conclusion, suggesting that spread of injected RNA is not
limiting (Figure 5E).
These data suggests that the phenotypic outcome of Wnt signaling in Xenopus embryos
responds to perturbations in the same way as predicted for the Wnt-induced fold-change in
β-catenin (Figures 5A, D, F). The phenotypic outcome of Wnt signaling does not correlate
with the absolute levels of β-catenin per se. The data suggests that, just like the Wnt-induced
fold-change in β-catenin, the phenotypic outcome of Wnt signaling is buffered against
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perturbations in the degradation machinery, while sensitive to β-catenin overexpression.
Fold-change in β-catenin, and not absolute level of β-catenin, seems to dictate the
phenotypic outcomes of Wnt signaling.
Transcriptional responses to Wnt signaling are robust to perturbations in the degradation
machinery
The observed phenotypic buffering suggests that either each target gene of β-catenin is
buffered, or that multiple target genes of β-catenin interact to give a robust phenotype. The
first scheme would place the fold-reading mechanism within the upstream regulation of each
target gene. The second scheme would place the fold-reading mechanism within a larger
transcriptional or developmental network. Expression of direct target genes of Wnt
signaling, measured much earlier than the morphological changes, is also insensitive to
perturbation of the degradation parameters (Figure 6A). Two direct target genes of the Wnt
pathway, siamois and Xnr3 (Lemaire et al., 1995; McKendry et al., 1997), were analyzed.
Despite a 2-fold increase in β-catenin level, expression of siamois and Xnr3 remained at a
wild-type level. With a higher dose of lithium (300mM), expression of siamois and Xnr3
finally increased, coinciding with the appearance of dorsalized phenotype in the population.
An even stronger lithium treatment leads to a greater increase in target gene expression,
confirming that transcription is not saturated (Figure S13). In contrast, expression of siamois
and Xnr3 changed readily when β-catenin was increased via β-catenin overexpression
(Figure 6B). Like the dorsoanterior phenotype, expression of direct target genes, siamois and
Xnr3, appear to correlate with fold-changes in β-catenin, and not absolute levels of β-
catenin.
The situation was very different with an exogenous promoter known as the TopFlash
reporter, which contains three repeats of Tcf binding sites upstream from a luciferase gene.
When the lithium perturbation experiment was repeated in the presence of the TopFlash
reporter, the luciferase activity increased steadily with lithium (Figure 6C), mimicking the
increase in β-catenin. The correlation between luciferase and β-catenin level, but not with
fold-change in β-catenin, was also observed in cultured cells (Figure 6D). A higher level of
β-catenin readily translated into a higher transcriptional activity (as read by luciferase
activity), but the phenotype and endogenous target genes remained unaltered.
DISCUSSION
To summarize, the data from mammalian cells showed experimentally that the Wnt-induced
fold-change in β-catenin is insensitive to perturbations in the degradation machinery (within
a range), but increased with β-catenin overexpression. The absolute level of β-catenin, by
contrast, shifts readily with all perturbations performed. Together with the measurements
from Xenopus (Lee et al., 2002), these data confirm that the there is indeed a region of
parameters where the fold-change in β-catenin can withstand naturally occurring variation in
cells, and suggest that the RKO cells and Xenopus operate within this parameter region.
The data from Xenopus suggest that the phenotypic and transcriptional outcomes of Wnt
signaling, just like the model prediction for the Wnt-induced fold-change in β-catenin, are
buffered to perturbations in degradation machinery (within a range), but sensitive to β-
catenin overexpression. Neither dorsoanterior phenotype nor transcription of target genes
appears to correlate with the absolute level of β-catenin in the embryo. In response to
inhibiting the degradation machinery, β-catenin level increased by ≤2-fold and the embryos
stayed wild type. In response to overexpressing β-catenin, β-catenin level increased by ≤2-
fold and the embryos became dorsalized. From the Xenopus setpoint, gradually inhibiting
degradation increases β-catenin levels without initially affecting fold-change in β-catenin
(i.e., cells respond to Wnt stimulation normally despite higher levels of β-catenin
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everywhere)—and the embryos initially remained wild type. From the Xenopus setpoint,
gradually increasing synthesis increases β-catenin levels as well as fold-change in β-catenin
(i.e., cells respond excessively to Wnt stimulation)—and dorsalized embryos appear readily.
Fold-changes in β-catenin, and not the absolute levels of β-catenin, appear to be a more
precise output of Wnt stimulation that correlates with the functional outcomes of Wnt
signaling in vivo.
The Wnt-induced fold-change in β-catenin can withstand cellular variation provided that the
parameters in the Wnt pathway are properly tuned. The Wnt pathway, with the fold-change
in β-catenin as the output as proposed here, would be robust because its functional outcomes
can be insensitive to biochemical parameters that naturally vary from cell to cell (how
robustness is currently defined (Alon, 2007; Barkai and Leibler, 1997; Stelling et al., 2004).
The Wnt pathway is merely one step in the complex process of dorsoanterior patterning in
Xenopus. We can imagine an alternative world where the dorsoanterior phenotype is robust
to perturbations in the internal cellular milieu, including to variation in the components of
the Wnt pathway, but the Wnt pathway itself is not robust. In this case there should be a
noisy and inaccurate level of β-catenin, which would then translate into a noisy
transcriptional outcome of Wnt signalling. To assure a normal phenotypic outcome under
these conditions, downstream processes would have to compensate for the noisy Wnt
signaling. The present study suggests that there is already a high degree of error checking
mechanism within the Wnt pathway itself. This robustness comes at a price, as it imposes
constraints on the downstream transcriptional circuits. It is a price that complex and modular
eukaryotic transcriptional machinery apparently can afford to pay.
How can a transcriptional system be built so that it is responsive to fold-changes in a
transcription factor, and not its absolute level? Intuitively, reading fold-changes in β-catenin
requires that cells remember the basal level of β-catenin before Wnt stimulation, and
compare it to the level of β-catenin after Wnt stimulation. It suggests that the cell tracks
signaling dynamics over time: it not only senses its present state, but actively compares it to
some previous state. In an accompanying theory paper, we discuss how a simple and
common network motif with a repressive feedforward can accomplish such a feat. The
repression might operate in cis-regulation, 3′-end regulation, chromatin modification, or
some other yet unknown features. Whereas patterning genes such as siamois and Xnr3
correlate with fold-changes in β-catenin, we would predict that some target genes, such as
those induced as signaling feedbacks, may respond to the absolute levels of β-catenin.
Reading fold-changes may be a common feature of biological systems. In an accompanying
paper, Cohen-Saidon and colleagues present evidence that in the ERK system, fold-changes
in the doubly phosphorylated ERK, and not its absolute levels, are the more reliable
response to ligand stimulation. This strategy is analogous to well known properties of
sensory systems in physiology. As described by Weber’s law, various sensory modalities
(e.g., hearing, vision, weight discrimination) detect the ratio of a new stimulus to the
background stimulus (fold difference) over a wide range (Weber, 1996). A novel implication
of our study is that such a ratio-sensing feature should also be found at the level of
transcription. Response to fold-change, as opposed to absolute level, might be a common
strategy in biological sensory systems, from the physiological to the molecular.
MATERIALS AND METHODS
Experiments in cultured cells
RKO cells (ATCC) are human colon carcinoma cells contains no known mutations in the
Wnt pathway, lacks E-Cadherin (Breen et al., 1993), and shows no membrane localization of
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β-catenin (Giannini et al., 2000). Cells were cultured in DMEM + 10% FBS, 10μg/mL L-
Glutamine, in a 37°C humidified incubator with 5% CO2. For each condition, temporal
profile of β-catenin accumulation was characterized to look for steady state.
Cell lysis—Cells were lysed in 0.5% NP-40, 150mM NaCl, 50mM Tris pH 7.6, 5 mM
EDTA, 1 mM PMSF, and Roche protease inhibitor cocktail (#11836153001). 2X Laemmli
was added to give a total protein concentration of 4-5 mg/mL, estimated using the Bradford
assay.
Dot blot—Far-red fluorescent signal was detected using the Odyssey system (Li-COR).
Primary antibodies: mouse monoclonal β-catenin (BD Signal Transduction #610154, 1:500),
rabbit polyclonal actin (Sigma A2066, 1:500). Secondary antibodies: goat-anti-mouse
IR800CW (LI-COR #926-32210, 1:5000), goat-anti-rabbit 680 (Alexa Fluor A-21076,
1:5000). 3-5 μL of cell lysate was dotted to nitrocellulose membrane, followed by Odyssey
staining protocol (http://biosupport.licor.com/support). Actin-normalized β-catenin signal
was used in all calculations. Fluorescent signal was linear across a 10-fold range: varying
dot volumes (0.3uL-3uL) were measured and a linear fit was obtained (R2=0.99). For each
experiment, 2-4 dot blots were performed; within each blot, each sample was dotted 1-3
times. Measurement uncertainty was propagated with standard methods. Sources of
uncertainty for estimating a fold-change in β-catenin: A sample dotted 10 times gave
fluorescent signal with CV=14%. Blot-to-blot variability: CV~10%. Between biological
repeats in each experiment: CV~20%.
Wnt stimulation—Wnt-conditioned medium (WCM) was collected from L-Wnt-3A
mouse fibroblast cells (ATCC). The control-conditioned medium (LCM) was collected from
L cells, the parental cell line (ATCC). The Wnt-induced fold-change of β-catenin was
identical using LCM or DMEM as the control. DMEM was subsequently used as the control
medium.
LiCl experiments—Cells were pre-incubated in LiCl for 3 hours, followed by
15min-24hour incubation in LiCl/DMEM or LiCl/WCM. Incubation in 80mM of NaCl for
27 hours did not alter β-catenin level (NaCl/DMEM=0.9±0.3). Pre-incubation of 3 or 6
hours did not make a significant difference.
β-catenin and Axin overexpression—Axin-GFP expression was obtained using
uninduced, leaky metallothionein promoter. β-catenin-GFP was constitutively expressed by
the CMV promoter. RKO cells were transduced with lentiviruses expressing the constructs.
Transduced cells were generous gifts from Ana Hernandez.
Experiments in Xenopus laevis embryos
Standard fertilization protocols were followed (Sive, 2000). Staging was based on
Nieuwkoop and Faber (Nieuwkoop, 1975). Unless specified, embryos developed at 16°C. In
all experiments, control embryos were the uninjected/untreated siblings from the same
fertilization batch.
Embryo homogenization—Protocol in (Guger and Gumbiner, 2000) was followed with
modifications. Ten stage 8 embryos were homogenized with pestle in 100μL lysis buffer
(0.5% NP-40, 150mM NaCl, 10mM Hepes-NaOH pH 7.4, 1.5mM NaEDTA, 1mM PMSF,
0.5mM iodoacetamide, 1μg/mL pepstatin A, 10μg/mL antipain, 50□g/mL benzamidine, and
Roche protease inhibitor cocktail, #11836153001). Cadherin-bound β-catenin was removed
using ConA-Sepharose4B beads (Figure S10). One-quarter volume of 5X Laemmli was
added to the final supernatant.
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Western blot—Far-red fluorescent signal was detected using the Odyssey system (Li-
COR). Primary antibodies: rabbit poyclonal β-catenin (Novus NB100-2141, 1:1000), rabbit
polyclonal actin (Sigma A2066, 1:500). Secondary antibodies: goat-anti-rabbit IR800CW
(LI-COR # 926-32211, 1:5000), goat-anti-rabbit 680 (Alexa Fluor A-21076, 1:5000). ~1/2
embryo (10-15μL) was loaded on 4-12% Bis/Tris gel (NuPage NP0321BOX), followed by
wet transfer. The Odyssey protocol was followed with modifications: 3-hour blocking and
>12h 4°C incubation in the primaries. The fluorescent signal was linear over > 3-fold range:
varying sample volume was loaded (5-20μL) and a linear fit was obtained (R2=0.96). A
sample loaded 6 times in the same gel gives fluorescent signal with 10% CV. For measuring
a fold-change, across blots: CV~10%. A 10-fold mistake in dilution allowed us to control
against a possible bias due to an a priori expectation of seeing a change (Table S1). 2-4
Western blots were performed in each experiment.
LiCl treatment—48- to 64-cell stage embryos were incubated in LiCl/0.1XMMR for 5
minutes (Kao and Elinson, 1988). See Table S1 for positive and negative controls.
RNA injection—Each blastomere in 4-cell stage embryos was injected (3nL) at the mid-
equatorial region (marginal zone). See Table S1 for full injection data. Technical controls:
no phenotypes were observed in embryos injected with equal volume of water or 1000pg
GFP. Constructs: Full-length Xenopus β-catenin (McCrea et al., 1991), Xenopus GBP
(Yost et al., 1998), mouse Axin1 (Zeng et al., 1997) were in pCS2+ vector, and transcribed
with mMessage mMachine (Ambion AM1340). A note on the Xbcat clone. The Xbcat
M77013 (McCrea et al., 1991) clone has 1 non-silent substitution at nucleotide 1920 when
compared to consensus sequences of β-catenin from X. laevis, X. tropicalis, mouse, human,
and plakogobin from mouse and human. We used site-directed mutagenesis (Stratagene
#200519) to mutate back n1920 (m1920 clone) and injected both transcripts. Both clones are
similarly potent.
Quantitative real-time RT-PCR—Embryos were collected from late stage 9, during
which siamois and Xnr3 expressions have plateaued (Figure S9). Total RNA was extracted
in Trizol and reverse-transcribed using QuantiTect RT (Qiagen #205310). Real-time RT-
PCR was performed using the QuantiTect Custom Assays (Qiagen) in BioRad iCycler iQ.
Two runs were performed per sample, with 4 technical repeats. See Table S2 for the FAM-
probe/primers sequences.
Phenotype scoring—Tadpoles at stage 40-41 were scored using the DAI index (Kao and
Elinson, 1988). Since mutants were weaker than their normal siblings, to avoid biasing the
phenotype, it was important to avoid overcrowding, remove dead embryos promptly, and
score repeatedly from day 3.5 onward. 15-150 embryos/batch were scored. Some batches
were photographed entirely and re-scored on other days.
Luciferase assay—Reporter constructs were injected to all 4 cells at 4-cell stage (100 pg
pTopFlash, Millipore 21-170 and 20 pg pRL-TK, Promega E2241). Lithium treatment was
performed at 32-cell stage. Luminescence was assayed in early gastrulaes (S10) using the
dual-luciferase Promega assay.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. What is the cellular reporter of Wnt stimulation?
(A) Wnt stimulation induces accumulation of β-catenin. (B) Together with the Tcf/Lef
transcription factor, β-catenin activates transcription of specific target genes. (C) We found
that the absolute level of β-catenin is sensitive to non-specific variation that may naturally
occur in cells. (D) Interestingly, the fold-change in β-catenin induced by Wnt stimulation is
buffered against variation in parameters. (E) Together with functional data from Xenopus
embryos, we propose that fold-changes in β-catenin, and not absolute levels of β-catenin, is
the output of Wnt signaling.
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Figure 2. Fold-change in β-catenin, not absolute levels, is predicted to be insensitive to variation
in cellular parameters
(A) A kinetic model of the Wnt pathway (Lee et al., 2003).
(B-C) Parameter sensitivity analysis. The parameters measured in the Xenopus extracts are
used as the “unperturbed setpoint” (the first column). From this setpoint, each parameter was
increased by 5-fold, one at a time (corresponds to each column). For each parameter set, we
simulated the accumulation of β-catenin induced by a step Wnt stimulation, and recorded the
level of β-catenin after Wnt stimulation (B) and fold-change in β-catenin induced by Wnt
(C).
Goentoro and Kirschner Page 17
Mol Cell. Author manuscript; available in PMC 2010 December 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(D-E) For example, when Axin1 synthesis rate is increased by 5-fold (D) and the system is
then stimulated with Wnt, the Wnt-induced level of β-catenin is 30 nM and the Wnt-induced
fold-change in β-catenin is 6-fold. When β-catenin synthesis rate is increased by 5-fold (E),
and the system is then stimulated with Wnt, the Wnt-induced level of β-catenin is 1200 nM
and the Wnt-induced fold-change in β-catenin is 9-fold. Please see Figure S1 for a more
complete sensitivity analysis.
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Figure 3. There is a region of parameters where the Wnt-induced fold-change in β-catenin is
insensitive to variation in parameters
(A-B) Analytical solutions for the level of β-catenin after Wnt stimulation (A) and the Wnt-
induced fold-change in β-catenin (B). These surfaces were computed analytically using
equations 29-30 derived in the supplement. The black dot denotes the Xenopus parameters
(α = 66, γ= 1). (C) The light blue shading indicates the region where the fold-change in β-
catenin varies by less than ±10%. Suppose the cells reside within this region (point a), and
we gradually inhibit degradation (α), thereby moving from point a to b to c. At each point,
we stimulate the cells with Wnt, shown in the right panel. The absolute levels of β-catenin
vary immediately, but the fold-change in β-catenin is identical for points a and b, which
reside within the blue-shaded region.
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Figure 4. The Wnt-induced fold-change in β-catenin is insensitive to perturbations in the
degradation machinery
In human RKO cells, most β-catenin is cytoplasmic due to absence of cadherin (Breen et al.,
1993; Giannini et al., 2000). In each experiment, 2-3 biological replicates were examined,
each analyzed using 2-4 dot blots. SD = standard deviation.
(A) A typical Wnt stimulation in RKO cells (i.e., incubation with Wnt3A-conditioned
media). Level of β-catenin was quantified using dot blot.
(B) Redrawn from Figure 3B. This figure predicts how the Wnt-induced fold-change in β-
catenin would respond to various perturbations, depicted by the arrows.
(C) Definition of the quantities measured in the experiments.
(D) Cells overexpressing Axin1 were stimulated with Wnt. Three independent experiments
were performed. 95%CI = 1.96*SD.
(E-F) Cells were pre-treated with different doses of lithium (3h), and then stimulated with
Wnt in the presence of lithium. Figure E shows representative profiles of Wnt-induced β-
catenin accumulation in the control and treated cells. Figure F shows results from 4
independent experiments. Please see Figure S4 for a detailed experimental protocol, and
Figure S6 for similar results using BIO, another GSK3β inhibitor.
(G) Cells overexpressing β-catenin were stimulated with Wnt. Two independent
experiments were performed. 95%CI = 1.96*SD.
(H) Cells overexpressing β-catenin were pre-treated with different doses of lithium (3h), and
then stimulated with Wnt in the presence of lithium. Three independent experiments were
performed.
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Figure 5. Phenotypic Outcome of Wnt Signaling in Xenopus Patterning Is Insensitive to
Perturbations in the Degradation Machinery
(A) Model prediction. To facilitate comparison with experimental data, we plot the Wnt-
induced fold-change in β-catenin against the basal level of β-catenin. (Please also see Figure
S8 to help visualize this.) From the Xenopus setpoint, perturbing degradation (α, green) will
vary β-catenin level without initially affecting the Wnt-induced fold-change in β-catenin.
However, increasing synthesis (γ, red) will increase both β-catenin level as well as the Wnt-
induced fold-change.
(B) RNA was injected to all four cells at 4-cell stage. Lithium treatment was performed at
48-cell stage for 5 min. Dorsoanterior phenotype was scored using the DAI index (Kao and
Elinson, 1988). Cadherin-free pool of β-catenin was quantified using western blot on stage
8, around the onset of target gene expression.
(C) Lithium treatment.
(D) Plotting median DAI versus measured level of β-catenin for lithium treatment, GBP
RNA injection, and Axin1 RNA injection.
(E and F) β-catenin injection. (F) Plotting median DAI versus measured level of β-catenin
for β-catenin RNA injection.
Note: Phenotypic scoring, β-catenin quantitation, and RT-PCR (in Figure 6) were performed
in sibling embryos. SD of β-catenin is from two to four western blots. For more raw data and
controls, see Table S1 . Sixty percent of the DAI 7/8 embryos developed as Janus twins
(Kao and Elinson, 1988). Image in (B) is reprinted from Kao and Elinson, 1988.
Goentoro and Kirschner Page 21
Mol Cell. Author manuscript; available in PMC 2010 December 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 6. Transcriptional outcome of Wnt signaling is insensitive to variations in the degradation
parameters
(A-B) Quantitative RT-PCR analysis of two direct target genes of the Wnt pathway, siamois
and Xnr3, in embryos treated with lithium (A) and injected with β-catenin RNA (B). RT-
PCR was performed at stage 10; SD = 2-3 measurements. Cadherin-free pool of β-catenin
was quantified at stage 8-9 using quantitative Western blot; SD = 2-4 blots.
(C) Embryos were injected with TopFlash and RL-TK constructs at 4-cells stage, and then
treated with lithium. Luciferase activity was assayed at stage 10.
(D) RKO cells stably expressing TopFlash construct was treated with lithium. β-catenin and
luciferase profiles were measured in the same experiment.
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